Muscat: It is not possible for those people who received the first dose of the "Pfizer-BioNTech " vaccine to receive the "AstraZeneca" vaccine as the second dose, the Minister of Health said.
A statement issued online by Oman News Agency (ONA), said: "On behalf of His Majesty Sultan Haitham Bin Tarik, the Government of the Sultanate and the Omani people, His Excellency Dr.Ahmed bin Mohammad Al-Saidi, Minister of Health, expressed his thanks and appreciation for the friendly Indian government for providing the doses of the vaccine against Covid-19 to the Sultanate."
His Excellency indicated in a press statement that: "The Serum Institute of India (SII) is one of the largest vaccine factories in the world. The Minister confirms that the step to obtain the vaccine reinforces the global efforts aimed at overcoming the Corona pandemic and to make vaccines available among all people of the world."
His Excellency clarified, "The vaccine will provide protection for everyone, that its effectiveness, safety and results have been laboratory-confirmed, and that it is important to have an interval of at least 4 weeks between the first and second dose when taking the AstraZeneca vaccine."
A statement issued online by Oman News Agency (ONA), said, "His Excellency the Minister of Health indicate that it is not possible for those who received the first dose of the "Pfizer-BioNTech " vaccine to receive the second dose of the "AstraZeneca" vaccine, and that the preliminary indications are that the new strain of Corona virus responds to treatment with the various vaccines manufactured for Covid-19."
He further said, "We cannot absolutely rule out the detection of new cases with new strains. The Minister confirmed that 4 cases have been recorded at laboratories in the Sultanate."